Merlin BioMed Group Overview

  • Investor Type
  • Venture Capital
  • Status
  • Inactive
  • Investments
  • 38
  • Portfolio
  • 1
  • Exits
  • 30
Exits

Merlin BioMed Group General Information

Description

Merlin BioMed Group was venture capital firm which used to invest in the biotechnology, pharmaceuticals, medical devices and healthcare care sectors.

Contact Information

Year Founded
1998
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
  • 230 Park Avenue
  • Suite 928
  • New York, NY 10169
  • United States

Merlin BioMed Group Investments (38)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
LK Technology Importacao E Exportacao 17-Jul-2013 Buyout/LBO 00000 Medical Supplies Profitable
0000000 0000000000 05-Jul-2012 0000 000.00 Biotechnology Profitable
000000000 00000000 30-May-2012 0000 0000 Drug Discovery Generating Revenue
00000 0 0000000000 04-Aug-2010 00000 00000 000 Pharmaceuticals Clinical Trials - Phase 2
0000000000 23-Oct-2009 0000 00.00 Surgical Devices Generating Revenue
0000000 0000000 24-Sep-2009 00000 00000 0000 Diagnostic Equipment Generating Revenue
0000000 0000000000 06-Sep-2009 00000 00000 00.00 Biotechnology Generating Revenue
00000000 000000000 12-Jun-2007 00000000000 00000 Therapeutic Devices Generating Revenue
AVEO Oncology 03-May-2007 Later Stage VC 0000 Biotechnology Profitable
Calypso Medical 21-Dec-2006 Later Stage VC 000.00 Diagnostic Equipment Generating Revenue
You’re viewing 10 of 38 investments. Get the full list »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Merlin BioMed Group Exits (30)

Company Name Exit Date Exit Type Exit Size
Euthymics Bioscience 01-Nov-2017 Merger/Acquisition
0000000 0000000 00 02-May-2016 000000000000000000 00.00
00000000 14-Nov-2014 000 00000
0000000 0000000000 27-Jan-2014 000
0000 0000000000000 09-Nov-2012 000000000000000000
0000000000 19-Mar-2012 0000000000: 000000
000 000000000000 02-Mar-2012 0000000000 00.000
0000000 0000000 19-Sep-2011 000000000000000000 000.00
Salient Surgical Technologies 31-Aug-2011 Merger/Acquisition 00000
Gemin X Pharmaceuticals 01-Apr-2011 Merger/Acquisition 00000
You’re viewing 10 of 30 exits. Get the full list »

Merlin BioMed Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial